Ryan advises public and private companies on US Securities and Exchange Commission compliance and reporting and capital-raising transactions. He has experience throughout the corporate life cycle, including early-stage capital raising, go-public transactions and public company advisory. His clients are primarily in the technology, biotech and healthcare sectors.
